Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

Cardiome Pharma (CRME) News Today

Cardiome Pharma logo
Jenny Sundqvist new CEO of InDex Pharmaceuticals
Get Cardiome Pharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for CRME and its competitors with MarketBeat's FREE daily newsletter.

CRME Media Mentions By Week

CRME Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CRME
News Sentiment

0.00

0.63

Average
Medical
News Sentiment

CRME News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CRME Articles
This Week

0

0

CRME Articles
Average Week

Get Cardiome Pharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for CRME and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:CRME) was last updated on 1/22/2025 by MarketBeat.com Staff
From Our Partners